Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China
- PMID: 19381688
- PMCID: PMC12160253
- DOI: 10.1007/s00432-009-0584-6
Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China
Abstract
Purpose: To evaluate current selection criteria for patients undergoing liver transplantation (LT) in response to hepatocellular carcinoma (HCC), and to analyze the prognostic factors for successful transplantation.
Methods: We evaluated the outcome of 1,078 consecutive patients with HCC from the Shanghai Multi-Center Collaborative LT Group who underwent LT over a 6-year period. Clinicopathologic data for these patients were evaluated. The prognostic significance was assessed using Kaplan-Meier survival estimates and log-rank tests. Multivariate study with Cox's proportional hazard model was used to evaluate the prognosis-relative aspects.
Results: We determined that expansion of Milan criteria to include: a solitary lesion < or = 9 cm in diameter, no more than three lesions with the largest < or = 5 cm, a total tumor diameter < or = 9 cm without macrovascular invasion, lymph node invasion and extrahepatic metastasis (referred to as the "Shanghai criteria"), resulted in overall survival (OS) and disease-free survival (DFS) rates that were similar to the Milan criteria. Multivariate analysis using the Cox proportional hazards regression model showed that the Child-Pugh-Turcotte classification (P = 0.010, 0.000), tumor differentiation (P = 0.001, 0.000), tumor size (P = 0.000, 0.000) and number (P = 0.014, 0.016), macrovascular invasion (P = 0.022, 0.000) and alpha-fetoprotein (AFP) levels (P = 0.031, 0.003) were independent predictors of OS and DFS, while post-LT chemotherapy (OS, P = 0.000) and tumor encapsulation (DFS, P = 0.038) were independent predictors of OS or DFS.
Conclusion: Shanghai criteria expanded the current criteria while maintaining similar survival.
Figures

Similar articles
-
Liver transplantation for hepatocellular carcinoma exceeding the Milan criteria: a single-center experience.J Cancer Res Clin Oncol. 2014 Feb;140(2):341-8. doi: 10.1007/s00432-013-1576-0. Epub 2013 Dec 30. J Cancer Res Clin Oncol. 2014. PMID: 24374832 Free PMC article. Clinical Trial.
-
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma.JAMA Surg. 2022 Sep 1;157(9):779-788. doi: 10.1001/jamasurg.2022.2800. JAMA Surg. 2022. PMID: 35857294 Free PMC article.
-
Risk assessment in liver transplantation for hepatocellular carcinoma: long-term follow-up of a two-centre experience.Int J Surg. 2024 May 1;110(5):2818-2831. doi: 10.1097/JS9.0000000000001104. Int J Surg. 2024. PMID: 38241354 Free PMC article.
-
Systematic review: the prognostic role of alpha-fetoprotein following liver transplantation for hepatocellular carcinoma.Aliment Pharmacol Ther. 2012 May;35(9):987-99. doi: 10.1111/j.1365-2036.2012.05060.x. Epub 2012 Mar 20. Aliment Pharmacol Ther. 2012. PMID: 22429190
-
Therapies for patients with hepatocellular carcinoma awaiting liver transplantation: A systematic review and meta-analysis.Hepatology. 2018 Jan;67(1):381-400. doi: 10.1002/hep.29485. Epub 2017 Nov 29. Hepatology. 2018. PMID: 28859222
Cited by
-
The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer.Ann Surg Oncol. 2017 Feb;24(2):526-534. doi: 10.1245/s10434-016-5500-0. Epub 2016 Aug 16. Ann Surg Oncol. 2017. PMID: 27531306 Free PMC article.
-
Transplant oncology - Current indications and strategies to advance the field.JHEP Rep. 2023 Nov 16;6(2):100965. doi: 10.1016/j.jhepr.2023.100965. eCollection 2024 Feb. JHEP Rep. 2023. PMID: 38304238 Free PMC article. Review.
-
Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria.World J Clin Cases. 2022 Oct 16;10(29):10413-10427. doi: 10.12998/wjcc.v10.i29.10413. World J Clin Cases. 2022. PMID: 36312504 Free PMC article. Review.
-
Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria.Ann Transl Med. 2022 Oct;10(20):1091. doi: 10.21037/atm-22-1353. Ann Transl Med. 2022. PMID: 36388794 Free PMC article.
-
Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review.J Clin Med. 2021 Aug 31;10(17):3932. doi: 10.3390/jcm10173932. J Clin Med. 2021. PMID: 34501381 Free PMC article. Review.
References
-
- Bismuth H, Majno PE, Adam R (1999) Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19:311–322. doi:10.1055/s-2007-1007120 - PubMed
-
- Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA (2006) Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 101:1797–1803. doi:10.1111/j.1572-0241.2006.00647.x - PubMed
-
- De Carlis L, Giacomoni A, Lauterio A, Slim A, Sammartino C, Pirotta V, Colella G, Forti D (2003) Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int 16:115–122. doi:10.1111/j.1432-2277.2003.tb00272.x - PubMed
-
- de Villa V, Lo CM (2007) Liver transplantation for hepatocellular carcinoma in Asia. Oncologist 12:1321–1331. doi:10.1634/theoncologist.12-11-1321 - PubMed
-
- Debruyne EN, Delanghe JR (2008) Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta 395:19–26. doi:10.1016/j.cca.2008.05.010 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical